$SLS News Article - SELLAS Announces Immune Respon
Post# of 88
(Total Views: 515)
Posted On: 06/03/2019 10:00:42 AM
$SLS News Article - SELLAS Announces Immune Response Data in Triple Negative Breast Cancer Patients from Phase 2b Study of Nelipepimut-S (NPS) Plus Trastuzumab Presented at ASCO 2019 https://marketwirenews.com/news-releases/sell...89380.html
(0)
(0)SELLAS Life Sciences Group, Inc. (SLS) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼